RxDoctor Payments Data

Ashley Vize, PA

Physician Assistant · Grayson, KYNPI 1295973147

Payments from drug & device makers

$4,077in general payments, 2019–2025

Across 266 payments — averaging $15.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$886
  • GSK$665
  • Lilly USA, LLC$503
  • Novo Nordisk$454
  • Boehringer Ingelheim$222
  • Takeda Pharmaceuticals U.S.A., Inc.$194
  • plus $1K from 25 others

What the payments were for

  • Food & beverage$4,077100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,077 in reported general payments places this provider in the 85th percentile of 1,448 physician assistant providers in Kentucky.

See all physician assistant providers in Kentucky

Medicare billing

Part B allowed, 2024
$19,003
Medicare patients
88
Services billed
385

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter23$20,054
LinzessLinaclotide15$16,866
MounjaroTirzepatide12$16,415
EliquisApixaban15$16,387
Breo ElliptaFluticasone/Vilanterol11$8,195
Ventolin HfaAlbuterol Sulfate31$3,015
Celecoxib24$2,215
Albuterol Sulfate HfaAlbuterol Sulfate28$1,333
Ezetimibe16$1,318
Potassium Chloride50$955
Levocetirizine Dihydrochloride60$929
Rosuvastatin Calcium68$894
FenofibrateFenofibrate Nanocrystallized33$876
Fluticasone Propionate61$726
Ropinirole Hcl28$717

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta$665$28,24934 claims
AbbVieLinzess$886$16,86615 claims
Lilly USA, LLCMounjaro$503$16,41512 claims
PfizerEliquis$125$16,38715 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,448 physician assistant providers in Kentucky.

Other physician assistant in Grayson

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →